Latest 8-K filings

RenovoRx announced record second quarter 2026 results with 61% sequential revenue growth, raised full-year revenue guidance to $3.75M-$4.25M, and achieved full enrollment in its Phase III TIGeR-PaC trial.

MultiSensor AI Holdings, Inc. announced second quarter 2026 financial results, highlighting a 19% revenue increase to $1.7 million and an 85% surge in software revenue to $0.7 million, alongside a reduced net loss.

Eikon Therapeutics announced second quarter 2026 financial results, highlighting clinical advancements in its oncology portfolio and a robust cash reserve.

ONE Gas, Inc. has entered into an underwriting agreement for the issuance and sale of $375 million in aggregate principal amount of 5.45% Senior Notes due 2036, with proceeds intended for debt repayment and general corporate purposes.

Serina Therapeutics announced second quarter 2026 financial results, reporting progress in its SER-252 clinical trial and a strategic partnership, while also detailing operating expenses and net loss.

Singularity Future Technology Ltd. announced it has regained compliance with Nasdaq's minimum bid price requirement, averting delisting concerns.

Digimarc Corporation announced its second quarter 2026 financial results, reporting a decrease in total revenue and subscription revenue, alongside an increased net loss.

Omeros Corporation announced the appointment of Joseph Schocken to its Board of Directors, effective August 12, 2026, expanding the board to nine members.

zSpace Inc. announced second quarter 2026 financial results, reporting a net income of $0.3 million compared to a net loss of $6.1 million in the prior year, driven by substantial gross margin expansion.

Bili Social International, Inc. has filed a Form 8-K to report the termination of its Series B Preferred Stock designation, effective August 7, 2026.

Applied Materials announced record third quarter 2026 revenue of $9.12 billion, a 25% year-over-year increase, with significant growth in EPS driven by strong demand for its materials engineering solutions.

Co-Diagnostics announced its second quarter 2026 financial results, highlighting progress in manufacturing, global clinical trials, and regulatory submissions, alongside a $3.0 million private placement.

ARS Pharmaceuticals announced a strategic pivot towards targeted provider engagement for its neffy product, alongside reporting Q2 2026 financial results, including $26.2 million in U.S. neffy net product revenue.

Silexion Therapeutics Corp. announced the pricing of a public offering, raising approximately $2.5 million to advance its SIL204 clinical trial.

TMC the metals company Inc. reported Q2 2026 results, highlighting progress in U.S. regulatory reviews and strategic partnerships, while continuing to manage operational costs and seeking U.S. government funding.

A Fifth Circuit Court of Appeals ruling vacates key portions of a rule impacting the No Surprises Act, potentially increasing reimbursement rates for healthcare providers like Nutex Health.

Soluna Holdings announced a 145% year-over-year revenue increase for Q2 2026, driven by operational improvements and a significant expansion of its AI-focused development pipeline.

DNA X, Inc. has filed an amendment to its Form 8-K to update disclosures regarding its equity position and its efforts to meet Nasdaq Capital Market continued listing requirements.

Kodiak Sciences reported Q2 2026 results, highlighting advancements in its late-stage clinical portfolio with key data readouts anticipated in late 2026, while also noting a net loss and reduced cash reserves.

Chilean Cobalt Corp. announced adjustments to the compensation packages for its CEO and CFO, including base salary increases and discretionary bonuses, effective August 2026.

Eco Science Solutions, Inc. has dismissed its independent auditor, Fruci & Associates II, PLLC, and appointed Dylan Floyd Accounting & Consulting as its new auditor.

Vestand Inc. has entered into a Stock Transfer Agreement to sell its entire stake in Vestand Korea Co., Ltd. to Mr. Sang-Woo Noh, with a repurchase option.

American Shared Hospital Services announced a 19% year-over-year revenue increase to $8.4 million for Q2 2026, primarily fueled by its Direct Patient Services segment, though net losses widened.

Magnolia Bancorp, Inc. announced the voluntary resignation of its Executive Vice President, Chief Financial Officer, and Secretary, Donice Wagner, effective August 21, 2026, leading to internal title adjustments.

Entergy Louisiana, LLC has successfully closed the sale of $1 billion in Collateral Trust Mortgage Bonds, split between a 5.50% Series due 2036 and a 6.20% Series due 2056.

AAON, Inc. announced its Board of Directors has declared a quarterly cash dividend of $0.10 per share, payable on September 25, 2026.

First National Corporation announced its quarterly cash dividend of $0.17 per common share, payable on September 11, 2026.

Digital Brands Group announced a major financial turnaround, forecasting positive cash flow starting September, driven by its collegiate program and expanding government contracts.

Epsilon Energy Ltd. has issued its production and capital guidance for Q3 and the full year 2026, outlining key drilling and completion activities across multiple basins.

Applied Industrial Technologies announced robust fourth quarter and full-year fiscal 2026 results, exceeding expectations with record quarterly performance and issuing positive guidance for fiscal 2027.